Ditchcarbon
  • Contact
  1. Organizations
  2. Nerhadou International for Pharmaceuticals and Nutraceuticals
Public Profile
Pharmaceutical Preparation Manufacturing
EG
updated 2 months ago

Nerhadou International for Pharmaceuticals and Nutraceuticals Sustainability Profile

Company website

Nerhadou International for Pharmaceuticals and Nutraceuticals, commonly referred to as Nerhadou, is a leading player in the pharmaceutical and nutraceutical sectors, headquartered in Egypt (EG). Established in 1999, the company has made significant strides in developing high-quality products that cater to both local and international markets, with a strong presence across the Middle East and North Africa. Nerhadou's core offerings include a diverse range of pharmaceuticals and nutraceuticals, distinguished by their commitment to innovation and quality. The company is renowned for its advanced manufacturing processes and adherence to international standards, ensuring the efficacy and safety of its products. With a robust market position, Nerhadou has achieved notable milestones, including numerous certifications and partnerships that underscore its reputation as a trusted provider in the industry.

DitchCarbon Score

How does Nerhadou International for Pharmaceuticals and Nutraceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Nerhadou International for Pharmaceuticals and Nutraceuticals's score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.

16%

Let us know if this data was useful to you

Nerhadou International for Pharmaceuticals and Nutraceuticals's reported carbon emissions

Nerhadou International for Pharmaceuticals and Nutraceuticals, headquartered in Egypt (EG), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. In the context of the pharmaceutical and nutraceutical industry, companies are increasingly recognising the importance of sustainability and climate commitments. While Nerhadou International has not yet established specific initiatives or targets, the industry as a whole is moving towards greater transparency and accountability in carbon emissions management. As the company develops its sustainability strategy, it may consider aligning with industry standards and frameworks, such as the Science Based Targets initiative (SBTi), to set measurable and impactful climate goals in the future.

How Carbon Intensive is Nerhadou International for Pharmaceuticals and Nutraceuticals's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Nerhadou International for Pharmaceuticals and Nutraceuticals's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Nerhadou International for Pharmaceuticals and Nutraceuticals's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Nerhadou International for Pharmaceuticals and Nutraceuticals is in EG, which has a medium grid carbon intensity relative to other regions.

Nerhadou International for Pharmaceuticals and Nutraceuticals's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Nerhadou International for Pharmaceuticals and Nutraceuticals has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Nerhadou International for Pharmaceuticals and Nutraceuticals's Emissions with Industry Peers

Pharco Pharmaceuticals Inc.

EG
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Herbalife

US
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Amoun Pharmaceutical Company S.A.E.

EG
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251119.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy